Commonwealth Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,407
Closed -$259K – 336
2026
Q2
$259K Buy
+5,407
New +$232K 0.03% 237

Other funds holding NVO

Commonwealth Financial Services's NVO Position: Q3 2026 in Review

Commonwealth Financial Services sold out of Novo Nordisk (NVO) in Q3 2026, closing a stake of 5,407 shares — an estimated $259K sold.

Commonwealth Financial Services first reported a position in NVO in Q2 2026 and held it in 1 quarter. The position peaked at $259K in Q2 2026. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Commonwealth Financial Services reported no remaining Novo Nordisk position as of Q3 2026 after selling out during the quarter.
  • Commonwealth Financial Services sold 5,407 Novo Nordisk shares in Q3 2026, an estimated $259K.
  • Commonwealth Financial Services first reported a position in Novo Nordisk in Q2 2026 and held it in 1 quarter.
  • Commonwealth Financial Services's Novo Nordisk position peaked at $259K in Q2 2026.
  • 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Commonwealth Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.